Yoshihiro Kamada

Osaka University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Jumpei Kondo

Associate Professor

Osaka University Graduate School of Medicine

JAPAN

View details

Makoto Fujii

Associate Professor (full-time)

Osaka University

JAPAN

View details

Takumi Kawaguchi

Kurume University School of Medicine

JAPAN

View details

Yoshio Sumida

Associate professor

Aichi Medical University

JAPAN

View details

Hidenao Noritake

Hamamatsu University School of Medicine

JAPAN

View details

Hiroshi Tobita

Shimane University Hospital

JAPAN

View details

Atsushi Nakajima

Yokohama National University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshihiro Kamada

Research Interests

Explore related searches

Contact this professor

Articles (10)

Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L

Enterococcus spp. have higher fitness for survival, in a pH‐dependent manner, in pancreatic juice among duodenal bacterial flora

Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD Patients

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

<i>Enterococcus</i> spp. have higher fitness for survival, in a pH-dependent manner, in pancreatic juice among duodenal bacterial flora

Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction–associated fatty liver disease

Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease

Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy

Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy

Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLD

Collaborators (7)

Jumpei Kondo

Makoto Fujii

Takumi Kawaguchi

Yoshio Sumida

Hidenao Noritake

Hiroshi Tobita

Atsushi Nakajima

Make your next move.